BAIBenevolentAI société anonymeBAI info
$0.88info-2.47%24h
Global rank21082
Market cap$103.16M
Change 7d-5.73%
YTD Performance-21.00%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    BenevolentAI société anonyme (BAI) Stock Overview

    BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

    BAI Stock Information

    Symbol
    BAI
    Address
    4-8 Maple StreetLondon, W1T 5HDUnited Kingdom
    Founded
    -
    Trading hours
    9:00 AM - 5:30 PM CET
    Website
    https://www.benevolent.com
    Country
    🇬🇧 United Kingdom
    Phone Number
    44 20 3781 9360

    BenevolentAI société anonyme (BAI) Price Chart

    -
    Value:-

    BenevolentAI société anonyme Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.8780704679337556
    N/A
    Market Cap
    $103.16M
    N/A
    Shares Outstanding
    117.49M
    N/A
    Employees
    260.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org